RANKL AS A PROGNOSTIC MARKER IN PATIENTS WITH BREAST CANCER
Sara Salama Ashour;
Abstract
Breast cancer is the third most common cancer in the world, and in 65% to 75% of patients, with progressive disease, bone metastases are common.
RANKL is implicated in the pathogenesis of bone metastasis at several levels; increased bone resorption as a r
RANKL is implicated in the pathogenesis of bone metastasis at several levels; increased bone resorption as a r
Other data
| Title | RANKL AS A PROGNOSTIC MARKER IN PATIENTS WITH BREAST CANCER | Other Titles | رانكل كدلالة منذرة لمرضى سرطان الثدى | Authors | Sara Salama Ashour | Keywords | RANKL AS A PROGNOSTIC MARKER IN PATIENTS WITH BREAST CANCER | Issue Date | 2011 | Description | Breast cancer is the third most common cancer in the world, and in 65% to 75% of patients, with progressive disease, bone metastases are common. RANKL is implicated in the pathogenesis of bone metastasis at several levels; increased bone resorption as a r |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| Binder1 كامله2.pdf | 951.57 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.